文献速递临床试验与 GCP真实世界研究与卫生经济

基于信息通信技术的集中式免疫抑制剂依从性监测系统在肾移植受者中的疗效与稳定性:随机对照试验研究方案

The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-10-16

本研究为前瞻性、开放标签、多中心随机对照试验,计划纳入2017至2018年注册的114例肾移植受者,随机分为基于信息通信技术的集中式家庭监测系统组或门诊随访组,随访6个月,比较两组用药依从性与移植结局,并评估患者满意度、系统稳定性与成本效果。

要点

  • 纳入114例肾移植受者,随机分为信息通信技术集中监测组与门诊随访组,随访6个月。
  • 监测系统由智能药盒、家庭监测系统、电子病例报告表系统与临床试验管理系统组成。
  • 主要比较两组用药依从性与移植结局,并评估患者满意度、系统稳定性与成本效果。

核心结论

  • 本研究预期确定持续使用所描述的信息通信技术集中监测系统能否最大化用药依从性并进而改善肾移植受者的移植结局。
  • 本研究将为成功实施该信息通信技术监测系统以有效管理肾移植受者用药依从性奠定基础。

研究设计与样本

  • 本研究为前瞻性、开放标签、多中心随机对照试验,旨在评估基于信息通信技术的集中式监测系统在提升肾移植受者用药依从性方面的疗效与稳定性。
  • 2017至2018年全年注册的114例肾移植受者被随机分配到基于信息通信技术的集中式家庭监测系统组或门诊随访组,计划随访6个月。

主要发现

  • 所描述的基于信息通信技术的集中式家庭监测系统由配备个人识别系统的智能药盒、家庭监测系统、电子病例报告表系统与综合临床试验管理系统组成。
  • 若出现剂量或给药时间错误或漏服,系统通过短信和药盒警报提醒患者和医务人员。
  • 比较两组随访期间的用药依从性与移植结局,并评估患者满意度以及该信息通信技术监测系统的稳定性与成本效果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunosuppression non-adherence in kidney transplant recipients (KTRs) not only increases the risk of medical intervention due to acute rejection and graft loss but burdens the socioeconomic system in the form of increased healthcare costs. An aggressive preemptive effort by healthcare professionals, geared to ensure adherence to immunosuppressants in KTRs, is significant and imperative. METHODS/DESIGN: This study was designed as a prospective, open-label, multicenter, randomized controlled study aimed at evaluating the efficacy and stability of an information and communication technology (ICT)-based centralized monitoring system in boosting medication adherence in KTRs. One hundred fourteen KTRs registered throughout the year 2017 to 2018 are randomized into either the ICT-based centralized home monitoring system or to ambulatory follow-up. The planned follow-up duration is 6 months. The ICT-based centralized home monitoring system described consists of a smart pill box equipped with personal identification system, a home monitoring system, an electronic Case Report Form (eCRF) system, and a comprehensive clinical trial management system (CTMS). It alerts both patients and medical staff with texts and pill box alarms if there is a dosage/dosing time error or a missed dose. Medication adherence and transplant outcomes for the follow-up period are compared between the two groups, while patient satisfaction as well as the stability and cost-effectiveness of the ICT-based monitoring system are to be evaluated. DISCUSSION: This on-going study is expected to determine if consistent use of the ICT-based centralized monitoring system described could maximize mediation adherence and subsequently enhance transplant outcomes in KTRs. Further, it would lay the foundation for successful implementation of this ICT-based monitoring system for effective management of medication adherence in KTRs. TRIALS REGISTRATION: ClinicalTrials.gov, Identifier: NCT03136588 . Registered on 20 April 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jung HY, Seong SJ, Choi JY, et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials. 2017. PMID: 29037222. doi:10.1186/s13063-017-2221-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。